<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03634696</url>
  </required_header>
  <id_info>
    <org_study_id>1040841</org_study_id>
    <secondary_id>R21TW010190</secondary_id>
    <nct_id>NCT03634696</nct_id>
  </id_info>
  <brief_title>m-Palliative Care Link: Improving Palliative Care for Late Stage Tanzanian Cancer Patients</brief_title>
  <official_title>m-Palliative Care Link: Improving Symptom Control and Information Exchange Among Specialists and Local Health Workers Treating Late Stage Tanzanian Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Susan Miesfeldt</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>MaineHealth</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dimagi Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Muhimbili University of Health and Allied Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fogarty International Center of the National Institute of Health</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>MaineHealth</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This work aims to improve late-stage cancer patients' access to high quality,&#xD;
      patient-centered symptom assessment and control via the creation, field test, and outcomes&#xD;
      assessment of a scalable mobile application (mPalliative Care Link; mPCL)-built around a&#xD;
      locally-validated Palliative care Outcome Scale- that links a limited pool of existing&#xD;
      Tanzanian palliative care specialists with patients, lay/family caregivers, and local health&#xD;
      workers.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators hypothesize that a mobile device-based symptom assessment, control and&#xD;
      communication application (m-Palliative Care Link (mPCL) will extend access to palliative&#xD;
      care specialists (hereafter named specialists), resulting in: a) symptom control information&#xD;
      exchange between specialists, patients, and local health workers and b) reduced symptom&#xD;
      burden in late-stage cancer patients.&#xD;
&#xD;
      This hypothesis will be tested by accomplishing the following specific aims in the two-year&#xD;
      study period:&#xD;
&#xD;
      Aim 1. In partnership with local palliative care specialists, to design and create a secure&#xD;
      mobile communication application (m-Palliative Care Link; mPCL) for facilitating remote&#xD;
      assessment of and communication about patient symptom control needs among specialists,&#xD;
      patients/caregivers, and local health workers (all of whom are referred to here as user&#xD;
      groups). mPCL will:&#xD;
&#xD;
        -  Regularly deliver the APCA POS (hereafter POS) to the cancer patient/caregiver via&#xD;
           mobile device; allow them to complete the outcome scale on this device; and return&#xD;
           responses to the specialist and local health worker for access via a secure website.&#xD;
&#xD;
        -  Enable specialist POS review/action in partnership with the local health worker.&#xD;
&#xD;
        -  Allow the specialist to communicate with the patient/caregiver and local health worker&#xD;
           regarding further symptom assessment and control based on existing standards and the&#xD;
           patient's desires and needs.&#xD;
&#xD;
        -  Enable the specialist to generate/update patient records for ongoing review.&#xD;
&#xD;
        -  Record and track symptom control as a trajectory throughout the patient's illness via&#xD;
           collection, storage, and analysis of POS responses.&#xD;
&#xD;
      Aim 2. To usability test an mPCL prototype through a combination of hands-on&#xD;
      observation/feedback and survey-based assessment of ease of use and suggestions for change&#xD;
      among 5-7 participants from each user group. Usability test data will be used to improve mPCL&#xD;
      design for subsequent field test (see Aim 3).&#xD;
&#xD;
      Aim 3. To field test and validate usability of mPCL among 45 late-stage cancer patients.&#xD;
      Late-stage cancer patients, who are eligible for the study, will be enrolled/consented,&#xD;
      trained on mPCL use, and provided with an mPCL-equipped mobile device prior to discharge from&#xD;
      ORCI. An mPCL record and discharge care plan will be generated by the specialist on his/her&#xD;
      personal computer and communicated with the patient's local health worker for review and&#xD;
      ongoing remote care communication and coordination. Field tests will continue for 4 months or&#xD;
      until patient death. Through a combination of surveys and interviews of user groups,&#xD;
      investigators will: determine the feasibility, acceptability, barriers, and facilitators of&#xD;
      mPCL for communication and action regarding symptom assessment, information exchange, and&#xD;
      symptom control; further optimize mPCL for ongoing study; determine the projected per patient&#xD;
      cost of mPCL implementation; and gather rich data on the symptom control needs of Tanzanian&#xD;
      cancer patients.&#xD;
&#xD;
      Aim 4. To collect preliminary data comparing field test symptom outcomes with 45 usual care&#xD;
      patients (ORCI palliative care clinic patients). Patients will be identified, enrolled and&#xD;
      consented during their scheduled outpatient clinic visit. POS responses will be collected at&#xD;
      the time of each clinic visit for up to 4 months. Through examination/between-group&#xD;
      comparisons (mPCL intervention versus usual care) of symptom-based outcomes and medication&#xD;
      type, dose and duration, investigators will collect preliminary data on mPCL impact that is&#xD;
      critical to design of a future large-scale, randomized mPCL outcomes study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 15, 2018</start_date>
  <completion_date type="Actual">July 20, 2021</completion_date>
  <primary_completion_date type="Actual">August 9, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain control</measure>
    <time_frame>Up to 4 months</time_frame>
    <description>APCA African Palliative Outcome Scale. Pain scale from 0-5 (low to high).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Application utility</measure>
    <time_frame>six week survey</time_frame>
    <description>Survey delivered via smart phone to all application users.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">98</enrollment>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>Field test participants</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Late-stage adult cancer patients seeking care at Ocean Road Cancer Center, consenting to participate in mPCL application field test</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control participants</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Late-stage adult cancer patients seeking care at Ocean Road Cancer Center, consenting to serve as controls for mPCL field test</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>mPCL</intervention_name>
    <description>Smart phone application to support palliative care among late-stage cancer patients</description>
    <arm_group_label>Field test participants</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual Care</intervention_name>
    <description>Usual care through OCRI palliative care clinic</description>
    <arm_group_label>Control participants</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients will be eligible for field test if they meet the following criteria:&#xD;
&#xD;
          -  Are ORCI inpatients with untreatable, late stage cancer&#xD;
&#xD;
          -  Age 21 years or older&#xD;
&#xD;
          -  Willing to enroll&#xD;
&#xD;
          -  Able to understand and sign informed consent document&#xD;
&#xD;
          -  Have four-month life expectancy or greater based on specialist assessment&#xD;
&#xD;
          -  Have caregivers available/willing to support outpatient care for duration of field&#xD;
             test&#xD;
&#xD;
          -  Have a local health worker to support their outpatient care who consents to&#xD;
             participate in the field test (i.e., partner with palliative care specialists for the&#xD;
             duration of field test)&#xD;
&#xD;
          -  Live within 50 km of ORCI for access to medications and study nurse support&#xD;
&#xD;
          -  Have experience using a mobile device as measured by past cell phone ownership&#xD;
&#xD;
          -  Have completed primary school&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        â€¢ Not meeting inclusion criteria&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susan Miesfeldt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MaineHealth</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ocean Road Cancer Institute</name>
      <address>
        <city>Dar Es Salaam</city>
        <country>Tanzania</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Tanzania</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>April 10, 2018</study_first_submitted>
  <study_first_submitted_qc>August 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 16, 2018</study_first_posted>
  <last_update_submitted>October 13, 2021</last_update_submitted>
  <last_update_submitted_qc>October 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>MaineHealth</investigator_affiliation>
    <investigator_full_name>Susan Miesfeldt</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Late-stage</keyword>
  <keyword>Palliative care</keyword>
  <keyword>Novel technology</keyword>
  <keyword>Communication</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

